Study conducted in collaboration with the Alzheimer’s Clinical Trials ConsortiumPURCHASE, N.Y., Nov. 13, 2025 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc., (the Company or Cognition) (NASDAQ: CGTX ...